Trends in the use of biologicals and their treatment outcomes among patients with inflammatory bowel diseases – a Danish nationwide cohort study

Summary Background Therapeutic management of inflammatory bowel diseases (IBD) is rapidly evolving, with an expanding armoury of biological drugs at our disposal. However, real‐world findings about treatment persistence and the impact of biologicals on surgery remain inconsistent. Aims This study ai...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Alimentary pharmacology & therapeutics 2022-03, Vol.55 (5), p.541-557
Hauptverfasser:	Zhao, Mirabella, Sall Jensen, Morten, Knudsen, Torben, Kelsen, Jens, Coskun, Mehmet, Kjellberg, Jakob, Burisch, Johan
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological products biological treatment Bowel disease Cohort analysis Cohort Studies Colitis, Ulcerative - surgery Crohn's disease Denmark - epidemiology direct cost Disease management epidemiology Humans Inflammatory bowel diseases Inflammatory Bowel Diseases - drug therapy Inflammatory Bowel Diseases - surgery Infliximab Intestine Monoclonal antibodies Patients Surgery Treatment Outcome Trends Tumor necrosis factor-α Ulcerative colitis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!